Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has obtained the Food and Drug Administration’s clearance for amphotericin B liposome for injection, 50 mg /vial, which is a generic of ...
Please provide your email address to receive an email when new articles are posted on . Irinotecan liposome injection combined with 5-FU/leucovorin and oxaliplatin prolonged OS compared with ...
Souderton, Pennsylvania, February 23, 2012 /PRNewswire/ — Galen, a Northern Ireland Pharmaceutical company, has acquired the chemotherapy agent, DaunoXome® (daunorubicin citrate liposome injection) ...
Sun Pharma has received the Food and Drug Administration’s blessing for generic Amphotericin B Liposome for injection, 50 mg/vial single-dose vial. Sun Pharma has been granted Competitive Generic ...
PARIS--(BUSINESS WIRE)-- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the United States Food and Drug Administration (FDA) has granted the company Fast Track designation for ...
In utero fetal gene transfer could provide an alternative to transgenic approaches for functional analysis of stage- and tissue-specific, cis-acting DNA regulatory elements. Stage-specific in utero ...
Please provide your email address to receive an email when new articles are posted on . An irinotecan liposome injection regimen improved OS compared with standard chemotherapy among untreated ...
Capstone Announces FDA Approval and EU Authorization of Doxorubicin Hydrochloride Liposome Injection
ROSEMONT, Ill., Dec. 14, 2022 /PRNewswire/ -- Capstone Development Services Company LLC ("Capstone") announced today that it has received approval from the U.S. Food and Drug Administration (FDA), as ...
Phase I study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting DLL3, in patients with small cell lung cancer (SCLC). This is an ASCO Meeting Abstract from ...
TAIPEI, Taiwan, March 5, 2016 /PRNewswire/ -- PharmaEngine, Inc. (TWO: 4162) announced that TFDA (Taiwan Food and Drug Administration) approved the product license of ONIVYDE(TM) (irinotecan liposome ...
BANNOCKBURN, Ill.--(BUSINESS WIRE)--Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and ...
Background Multimodal analgesia following total hip arthroplasty has been shown to improve patient satisfaction, participation with physical therapy, and allow early return to self care. Liposomal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results